The verdictOn regulation, the evidence now leans clearly positive: The Long Mott safety evaluation is finished and has been through the mandatory hearing (2026-09-22) and the ACRS full committee (2026-10-07). The only intervention was dismissed in June. A construction permit by Q1 2027 looks likely. On commercial terms, it leans negative: Two months after the "final throes" claim there is still no binding plant order and noβ¦
Written by Claude (Anthropicβs AI) from public sources Β· Willem owns XE Β· AI can make mistakes β numbers in brackets point to the sources Β· Not financial advice
Bull arguments show how well they survive the devilβs advocate (strong / medium / weak); bear arguments show the damage they could do after the counter-argument (high / medium / low).
| Basis | Burn | Runway on $1.90B |
|---|---|---|
| Q2 operating cash flow plus capex after DOE reimbursement | $137.1M per quarter | ~42 months |
| Q2 operating cash flow plus gross capex | $160.6M per quarter | ~35 months |
| Year | Hours online | Net output | Load factor |
|---|---|---|---|
| 2024 | 6,329 | 206 GWh | 15.6% |
| 2025 | 4,552 | 576 GWh | 43.8% |
The point: The anchor customer secured terms that limit pricing and margins for a decade.
Evidence: Amazon has [1,3]:
A buyer of the manufacturing assets inherits these obligations.
Why it matters: These terms erode the fuel and service margins at the core of the bull case. Other buyers queue behind Amazon.
π‘οΈ Counter-argument: Without Amazon there may be no fleet. Payments back can be deferred if they exceed a share of free cash flow [1].
Severity: Medium.
Consensus is thin and of low quality:
Interpretation: the ~4Γ revenue step-up in FY2027 most likely assumes Long Mott construction-phase work billed under ARDP, but analysts' assumptions are not public. ARDP revenue is cost-based at roughly zero or negative margin, so revenue changes move EPS little. Impacts below use EBITDA or FCF per share on 414.15M fully diluted shares [6].
Amazon exercises fleet options beyond Cascade, or a second hyperscaler signs β 20% chance within 36 months
A binding ~1 GW investor-owned-utility development agreement β 45% chance by 2027-06-30
Long Mott permit issued before the end of 2026 β 33% chance by 2026-12-31
Federal debt replaces equity for TX-2 β 30% chance within 24 months
TX-1 sells TRISO fuel to third parties β 12% chance within 36 months
ARDP cost overrun above DOE's raised cap lands partly on X-energy β 30% chance within 36 months
Dow delays its FID beyond 2028 or exits β 30% chance within 36 months
ARDP continuation delayed or cut in FY2027 appropriations β 12% chance by 2027-09-30
Equity or convertible raise before 2028 without new orders β 35% chance within 24 months
Cascade application slips a second time (after 1H 2027) β 30% chance by 2027-06-30
| # | Factor | Weight | Measured value | Score | Why |
|---|---|---|---|---|---|
| 1 | Liquidity & funding runway | 15% | $1,899.8M liquidity, no debt; Q2 burn $137β161M/qtr β runway ~35β42 months; supplier prepayments rising, TX-2 unfunded | 50 | Runway above 36 months on most measures, but burn is accelerating toward the 35-month end. |
| 2 | Leverage | 10% | Net cash ~$1.9B; zero debt; ~$27M of lease liabilities; TRA ~$770M contingent | 15 | Net cash. The TRA is contingent on profits, so it adds little. |
| 3 | Dilution | 10% | 82 | More than +25% over 12 months; forward overhang alone is ~8β12%. | |
| 4 | Profitability | 10% | Q2 FCF margin β251%; operating margin β202%; gross margin β58.7%; adjusted EBITDA β$70.5M | 85 | Deep losses on cost-share revenue; no commercial product revenue before the early 2030s. |
| 5 | Revenue quality & concentration | 10% | DOE 87.3% of Q2 revenue (US government 90.3%); one program; no backlog disclosed; no binding plant order | 80 | More than 35% from one customer, tied to one project. |
| 6 | Execution & track record | 10% | Material weakness FY23βFY25, unremediated; ARDP demo 2027β28 β early 2030s; Cascade +6 months; 1 GW deal overdue; NRC milestones and the TX-1 shell on time | 76 | The material weakness and a multi-year program slip point to the top band. Recent dated milestones hit, so not 81+. |
| 7 | Competitive position & disruption | 10% | Only licensed commercial TRISO plant; BWRX-300, Natrium and Hermes 2 already building; Standard Nuclear scaling TRISO | 60 | Contested: a fuel moat, but 2β4 years behind on the reactor. |
| 8 | Cyclicality & commodity/macro | 10% | Revenue is federal cost-share (not cyclical); customer FIDs depend on Dow's chemical cycle (BBB-/Baa3 negative) and rates; HALEU supply | 50 | Cyclical through its customers, not its own revenue. |
| 9 | Regulatory, legal & geopolitical | 5% | Pending Long Mott permit (likely positive); ARDP FY27 request β16%; continuation due by March 2027; Russia enrichment ban; no material litigation | 65 | Large pending federal decisions, but the trend is supportive. |
| 10 | Valuation & expectations | 10% | $13.08 Γ 414.15M β $5.42B; EV β $3.67B (est. ~$1.75B liquidity at 09-30) β 17x FY26 / ~4.3x FY27 cons revenue, $0.32B per GW of optioned pipeline; short interest 6β10% of float, ~3.7 days to cover; β65% vs the $37.10 peak | 62 | No order book under a ~$3.7B EV still assumes success, though expectations have reset a lot. |
Overall: weighted average = 0.15Γ50 + 0.10Γ15 + 0.10Γ82 + 0.10Γ85 + 0.10Γ80 + 0.10Γ76 + 0.10Γ60 + 0.10Γ50 + 0.05Γ65 + 0.10Γ62 = 61.75 β 62. Change vs last: 0. The method changed, so this is not a like-for-like comparison. Underneath:
Ranking check: At 62 XE sits between FRVO (61) and ELVA (63):